Concepedia

Darin Smith

DS

19

Publications

2.1K

Citations

18

H-Index

1991

Active since

Affiliations

Array BioPharma (United States)(Current)

Bolder Biotechnology, Inc.

University of Colorado Boulder

AVEO Oncology (United States)

Darin Smith is an author at Array BioPharma (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

1991–2020

19

Publications

19

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Tammie C. Yeh, Vivienne Marsh, Bryan A. Bernat et al. · Clinical Cancer Research · 2007 · 575 citations · Full text

Identification of the Clinical Development Candidate <b>MRTX849</b>, a Covalent KRAS<sup>G12C</sup> Inhibitor for the Treatment of Cancer

Jay B. Fell, John P. Fischer, Brian R. Baer et al. · Journal of Medicinal Chemistry · 2020 · 559 citations · Full text

Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling

Jacob R. Haling, Jawahar Sudhamsu, Ivana Yen et al. · Cancer Cell · 2014 · 247 citations · Full text

, , +7

A Long-Acting, Highly Potent Interferon α-2 Conjugate Created Using Site-Specific PEGylation

Mary S. Rosendahl, Daniel H. Doherty, Darin Smith et al. · Bioconjugate Chemistry · 2005 · 106 citations

, , +14

Site-Specific PEGylation of Engineered Cysteine Analogues of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor

Daniel H. Doherty, Mary S. Rosendahl, Darin Smith et al. · Bioconjugate Chemistry · 2005 · 77 citations · Full text

, , +19

Rows per page

1–5 of 19